Phase I Trial of Everolimus and Capecitabine in Metastatic HER2 [electronic resource]
Producer: 20180529Description: 418-426 p. digitalISSN:- 1938-0666
- Administration, Oral
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Breast Neoplasms -- drug therapy
- Capecitabine -- administration & dosage
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Everolimus -- administration & dosage
- Female
- Humans
- Maximum Tolerated Dose
- Middle Aged
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.